The use of high-flow nasal oxygen in COVID-19

Anaesthesia

Volumn 75, Issue 7, 2020, Pages 843-847

  Lyons, C ^a   Callaghan, M ^b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

aerosolisation; COVID 19; high flow nasal oxygen; respiratory failure; tracheal intubation

Indexed keywords

HIGH FLOW NASAL OXYGEN; OXYGEN; UNCLASSIFIED DRUG;

AEROSOL; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; CORONAVIRUS DISEASE 2019; EDITORIAL; ENDOTRACHEAL INTUBATION; HUMAN; INFECTION RISK; NONINVASIVE VENTILATION; OXYGEN THERAPY; PATIENT CARE; PNEUMONIA; RESPIRATORY FAILURE; RISK BENEFIT ANALYSIS; BETACORONAVIRUS; COMPLICATION; CORONAVIRUS INFECTION; PANDEMIC; PROCEDURES; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; NONINVASIVE VENTILATION; OXYGEN INHALATION THERAPY; PANDEMICS; PNEUMONIA, VIRAL; RESPIRATORY INSUFFICIENCY;

EID: 85083651232     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.15073     Document Type: Editorial

References (19)

1. Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. New England Journal of Medicine 2015; 272: 2185–96.
2. Rochwerg B, Granton D, Wang DX, et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Medicine 2019; 45: 563–72.
3. Faculty of Intensive Care Medicine, Intensive Care Society, Association of Anaesthetists and Royal College of Anaesthetists. Critical care preparation and management in the COVID-19 pandemic - 17 March 2020. www.icmanaesthesiacovid-19.org/critical-care-preparation-and-management-in-the-covid-19-pandemic (accessed 25/03/2020).
4. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance - 13 March 2020. www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected (accessed 25/03/2020).
5. ANZICS COVID-19 Working Group. The Australian and New Zealand Intensive Care Society COVID-19 Guidelines (Version 1; 16 March 2020). www.anzics.com.au/wp-content/uploads/2020/03/ANZICS-COVID-19-Guidelines-Version-1.pdf (accessed 25/03/2020).
6. Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). www.esicm.org/wp-content/uploads/2020/03/SSC-COVID19-GUIDELINES.pdf (accessed 25/03/2020).
7. Leung CCH, Joynt GM, Gomersall CD, et al. Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial. Journal of Hospital Infection 2019; 101: 84–7.
8. Loh NHW, Tan Y, Taculod J, et al. The impact of high-flow nasal cannula (HFNC) on coughing distance: implications on its use during the novel coronavirus disease outbreak. Canadian Journal of Anaesthesia 2020. Epub ahead of print 18 March. https://doi.org/10.1007/s12630-020-01634-3
9. Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high flow nasal cannula therapy versus CPAP via different masks. European Respiratory Journal 2019; 53: 1802339.
10. Kotoda M, Hishiyama S, Mitsui K, et al. Assessment of the potential for pathogen dispersal during high-flow nasal therapy. Journal of Hospital Infection 2019. Epub ahead of print 20 November. https://doi.org/10.1016/j.jhin.2019.11.010
11. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS ONE 2012; 7: e35797.
12. Parke RL, Bloch A, McGuinness SP. Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers. Respiratory Care 2015; 60: 1397–403.
13. Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID-19. Anaesthesia 2020; 75: 785–99.
14. Lyons C, Callaghan M. Uses and mechanisms of apnoeic oxygenation: a narrative review. Anaesthesia 2019; 74: 497–507.
15. Ding L, Wang L, Wanhong M, Hangyong H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Critical Care 2020; 24: 28.
16. Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Annals of Intensive Care 2020; 10: 33.
17. Centers for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19) 7 March 2020. www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html (accessed 25/03/2020)
18. Liu Y, Yan LM, Xiang TX, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infectious Diseases 2020. Epub ahead of print 19 March. https://doi.org/10.1016/s1473-3099(20)30232-2
19. Cheng PKC, Wong DA, Tong LKL, et al. Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 2004; 363: 1699–700.